Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,043,717
  • Shares Outstanding, K 128,695
  • Annual Sales, $ 660,570 K
  • Annual Income, $ -78,730 K
  • EBIT $ -89 M
  • EBITDA $ -14 M
  • 60-Month Beta 1.60
  • Price/Sales 1.53
  • Price/Cash Flow 17.87
  • Price/Book 1.14

Options Overview Details

View History
  • Implied Volatility 56.11% ( -15.13%)
  • Historical Volatility 137.99%
  • IV Percentile 56%
  • IV Rank 29.69%
  • IV High 121.33% on 04/10/25
  • IV Low 28.57% on 11/27/24
  • Put/Call Vol Ratio 0.03
  • Today's Volume 1,490
  • Volume Avg (30-Day) 1,389
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 27,695
  • Open Int (30-Day) 22,553

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.04
  • Number of Estimates 6
  • High Estimate -0.02
  • Low Estimate -0.06
  • Prior Year -0.04
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.08 +33.39%
on 04/30/25
10.51 -22.84%
on 04/28/25
-1.45 (-15.17%)
since 04/16/25
3-Month
6.08 +33.39%
on 04/30/25
13.30 -39.02%
on 02/18/25
-6.31 (-43.76%)
since 02/14/25
52-Week
6.08 +33.39%
on 04/30/25
19.11 -57.57%
on 01/08/25
-6.88 (-45.90%)
since 05/16/24

Most Recent Stories

More News
It's Not Too Late to Jump on These Under-the-Radar Momentum Plays

These three stocks may fly under the radar, but their recent price increases could appeal to investors seeking a momentum play.

FIX : 471.97 (+1.86%)
NEO : 8.11 (+3.44%)
ODD : 63.00 (-0.40%)
3 Small-Cap Stocks Walking a Fine Line

3 Small-Cap Stocks Walking a Fine Line

ACHC : 26.15 (+1.99%)
SPT : 23.90 (+0.63%)
NEO : 8.11 (+3.44%)
Why NeoGenomics (NEO) Stock Is Nosediving

Why NeoGenomics (NEO) Stock Is Nosediving

NEO : 8.11 (+3.44%)
Why NeoGenomics (NEO) Stock Is Nosediving

Why NeoGenomics (NEO) Stock Is Nosediving

NEO : 8.11 (+3.44%)
NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops

NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops

NEO : 8.11 (+3.44%)
NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops

NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops

NEO : 8.11 (+3.44%)
NeoGenomics: Q1 Earnings Snapshot

NeoGenomics: Q1 Earnings Snapshot

NEO : 8.11 (+3.44%)
NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For

NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For

DGX : 177.97 (+0.88%)
NEO : 8.11 (+3.44%)
CNC : 61.78 (+2.86%)
Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)

Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)

GH : 40.67 (+0.52%)
DGX : 177.97 (+0.88%)
NEO : 8.11 (+3.44%)
LH : 249.52 (+1.32%)
RDNT : 61.14 (+1.46%)
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

GH : 40.67 (+0.52%)
DGX : 177.97 (+0.88%)
NEO : 8.11 (+3.44%)
LH : 249.52 (+1.32%)
RDNT : 61.14 (+1.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 8.68
2nd Resistance Point 8.41
1st Resistance Point 8.26
Last Price 8.11
1st Support Level 7.84
2nd Support Level 7.58
3rd Support Level 7.43

See More

52-Week High 19.11
Fibonacci 61.8% 14.14
Fibonacci 50% 12.60
Fibonacci 38.2% 11.06
Last Price 8.11
52-Week Low 6.08

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar